-
C5 inhibitors are not C5a inhibitors
Lim, E. H. T., Vlaar, A. P. J., de Bruin, S., Brouwer, M. C. & van de Beek, D., 29 Mar 2023, (E-pub ahead of print) In: Expert Review of Anti-Infective Therapy.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Biotinylated Platelets: A Promising Labeling Technique?
van Wonderen, S. F., van Baarle, F. L. F., de Bruin, S., Peters, A. L., de Korte, D., van Bruggen, R. & Vlaar, A. P. J., 2023, (E-pub ahead of print) In: Transfusion medicine reviews.Research output: Contribution to journal › Article* › Academic › peer-review
-
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
PANAMO study group, 1 Dec 2022, In: Lancet respiratory medicine. 10, 12, p. 1137-1146 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
